Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B.

导出 OA

翻译打印收藏纠错

第一作者： Chung-Il,Wi

第一单位： Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA.

作者： Chung-Il,Wi ^[1] ; W Ray,Kim ^[1] ; John B,Gross ^[2] ; Linda M,Stadheim ^[1] ; John J,Poterucha ^[1]

作者单位： Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA. ^[1] Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA. ^[2]

关键词 Combination antiviral therapy Entecavir or tenofovir HBe seroconversion HBeAg-positive chronic hepatitis B Pegylated interferon

主题词青少年(Adolescent);成年人(Adult);抗病毒药(Antiviral Agents);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);鸟嘌呤(Guanine);乙型肝炎e抗原(Hepatitis B e Antigens);乙型肝炎, 慢性(Hepatitis B, Chronic);人类(Humans);干扰素α(Interferon-alpha);男(雄)性(Male);中年人(Middle Aged);聚乙烯二醇类(Polyethylene Glycols);重组蛋白质类(Recombinant Proteins);治疗结果(Treatment Outcome)

DOI 10.5009/gnl14256

PMID 26190580

发布时间 2018-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览13

Gut and liver

2016年10卷4期

611-6页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B.

Gut and liver

相似文献

Gut and liver

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B.

Gut and liver

相似文献

Gut and liver

相关期刊

检索历史清除